“I suspect the femtocell has missed its chance,” wrote Charles Arthur in the Guardian recently. Not so fast. It seems the existing shareholders of femtocell manufacturer Ubiquisys beg to differ, because they’ve just pumped a further $11m into the company.

The money will fund a range of consumer and enterprise products, to be deployed globally over the coming year. Ubiquisys’ investors include Accel, Atlas Venture, Google and the T-Mobile Venture Fund.